SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks

Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08703-3. Online ahead of print.

Authors

Alejandro J Loyola-Vélez¹, Binu V John^{2

3}

Affiliations

¹ Florida International University and Miami VA Medical System, Miami, FL, USA. alejandro.loyola-velez@va.gov.
² Division of Gastroenterology and Hepatology, Miami VA Medical System, Miami, USA.
³ Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.

PMID: 39581899
DOI: 10.1007/s10620-024-08703-3

No abstract available

Publication types

Editorial

Grants and funding